Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathwaySomsiri Indramanee(Khon Kaen University), Sopit Wongkham(Khon Kaen University)Scientific ReportsNovember 21, 201910.1038/s41598-019-53601-8Cited by 28SaveCiteExport RISWatch citationsRelated PapersCepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF‐κB|Cancer Science|2010|75Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy|PLoS ONE|2014|49